North America Genetic Testing Services Market Forecast to 2030

North America Genetic Testing Services Market Forecast to 2030

North America Genetic Testing Services Market Forecast to 2030 – Regional Analysis – by Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases, and Other Diseases), and Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others)

Send Enquiry
Item ID: TIPRE00009262 Category: Tag:

$2,485 – $3,885

Description

The North America genetic testing services market was valued at US$ 1,604.32 million in 2022 and is expected to reach US$ 4,984.25 million by 2030; it is estimated to register a CAGR of 15.2% from 2022 to 2030.

Growing Preference for Direct-To-Consumer (DTC) Genetic Testing Fuels North America Genetic Testing Services Market

Personalized genetic testing and treatment have long been used globally to help individuals and families learn more about hereditary diseases. Most of the time, genetic testing is done through healthcare personnel, such as genetic counselors. Healthcare providers decide which test is needed, order the test from a test center, collect and send the DNA sample, read the test results, and share the results with the patient. Thus, these tests have traditionally been ordered and interpreted in a clinical or medical research setting. In contrast, DTC genetic testing has witnessed tremendous growth in the past decade and is becoming increasingly widespread.

A genetic test offered, advertised, and sold by companies directly to the consumer, without the direct involvement of a conventional healthcare system, is called DTC genetic testing. DTC genetic testing is relatively new and helps people find out about the disease-associated genes they may carry without the need for a prescription or guidance from a genetic counselor or medical practitioner. Several consumers of DTC testing view it as another method of gathering medical information about themselves.

Unlike other genetic tests performed in clinics or hospitals, the consumer independently initiates and completes a DTC genetic test. The public understanding and acceptance of genetic testing is gradually increasing. Additionally, there is a rise in consumers seeking customized products and experiences for the identification and addressing of unique needs. The launch of innovative products and the increase in the adoption of DTC genetic testing kits have made genetic testing more accessible to people. These kits enable users to undergo personalized health management within the comfort of their homes.

Key industry players are also developing DTC genetic tests and implementing special marketing efforts that positively impact sales of DTC tests. In April 2017, the US Food and Drug Administration (FDA) gave genetics company 23andMe the consent to market DNA tests evaluating the user’s level of risk for ten health conditions, including late-onset Alzheimer’s disease and Parkinson’s disease. These remain the only FDA-approved DTC tests for genetic risk of infection. In July 2023, Quest Diagnostics, a US-based diagnostic information service provider, introduced its first direct-consumer genetic test, Genetic Insights. The test uses next-generation sequencing to evaluate the risk for inheritable health conditions. The test inspects 36 genes using a saliva sample. It can investigate the potential risk of up to 24 genetically inheritable conditions, including breast cancer, heart disorders, blood disorders, and sickle cell anemia.

A rising number of manufacturers are providing direct-to-consumer genetic testing that covers various health conditions and traits. The increasing demand for direct-to-consumer genetic testing products to learn about the genetic makeup and assess the risk of developing hereditary conditions for early disease detection or prevention drives the market.

North America Genetic Testing Services Market Overview

The North America genetic testing services market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during 2022–2030. The North America genetic testing services market in North America is expected to grow due to the rising number of cancer patients, increasing government funding, and rising incidence of genetic diseases among the population in the US and Canada during recent years. Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for the promotion of precision medicine, and massive funds from government and private bodies for genetic research contribute to exceptional revenue generation for the North America genetic testing services market in North America.

North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

North America Genetic Testing Services Market Segmentation

The North America genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the North America genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the North America genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the North America genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the North America genetic testing services market is segmented into the US, Canada, and Mexico. The US dominated the North America genetic testing services market share in 2022.

23andMe Holding Co, Ambry Genetics Corp, Eurofins Scientific SE, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Illumina Inc, Laboratory Corp of America Holdings, NeoGenomics Inc, Centogene AG, and Quest Diagnostics Inc are among the leading companies operating in the North America genetic testing services market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 15.2% CAGR, North America Genetic Testing Services Market is Speculated to be Worth US$ 4,984.25 Million by 2030, says the Research Team

According to the Research Team’ research, the North America genetic testing services market was valued at US$ 1,604.32 million in 2022 and is expected to reach US$ 4,984.25 million by 2030, registering a CAGR of 15.2% from 2022 to 2030. Rising prevalence of genetic diseases and growing preference for direct-to-consumer (DTC) genetic testing are among the critical factors attributed to drive the North America genetic testing services market growth.

The prevalence of genetic diseases is rising across the world and impacting the health of people at a severe level. Genetic diseases show many symptoms that are uncommon and are mostly non-curable. Most of the genetic diseases are rare and are developed due to the mutation in the genetic makeup of the people. According to The World Health Organization (WHO) 2021, 10 out of every 1,000 people are affected by single-gene diseases, signifying that 70 million and 80 million people worldwide are living with any one type of single-gene disease. As per the Global Genes, ~7,000 known rare diseases and disorders have been identified worldwide, and more are being discovered every year. According to the University of Sheffield research, ~300 million people are living with genetic diseases around the world. In 2022, a report by MJH Life Sciences (US) estimated that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ∼ 5% of the global population. Also, as per the study titled “Sickle Cell Disease,” published in August 2023, 1 in 500 African Americans is affected by sickle cell disease, and ∼ 1 in 12 African Americans carry the autosomal recessive mutation. Thus, the rising prevalence of genetic diseases fuels the demand for genetic testing, which in turn drives genetic testing services market growth.

On the contrary, the social and ethical implications of genetic testing hamper the growth of North America genetic testing services market.

Based on service type, the North America genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held 39.7% market share in 2022, amassing US$ 637.06 million. It is projected to garner US$ 2,165.31 million by 2030 to register 16.5% CAGR during 2022–2030.

In terms of disease, the North America genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases . The cancer segment held 45.1% share of North America genetic testing services market in 2022, amassing US$ 723.77 million. It is anticipated to garner US$ 2,460.90 million by 2030 to expand at 16.5% CAGR during 2022–2030.

By service provider, the North America genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held 62.7% share of North America genetic testing services market in 2022, amassing US$ 1,005.93 million. It is projected to garner US$ 3,356.93 million by 2030 to expand at 16.3% CAGR from 2022 to 2030.

Based on country, the North America genetic testing services market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 81.5% share of North America genetic testing services market in 2022. It was assessed at US$ 1,306.93 million in 2022 and is likely to hit US$ 4,208.99 million by 2030, registering a CAGR of 15.7% during 2022–2030.

Key players operating in the North America genetic testing services market are 23andMe Holding Co, Ambry Genetics Corp, Eurofins Scientific SE, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Illumina Inc, Laboratory Corp of America Holdings, NeoGenomics Inc, Centogene AG, and Quest Diagnostics Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America genetic testing services market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America genetic testing services market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Genetic Testing Services Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Prevalence of Genetic Diseases
4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
4.2 Market Restraints
4.2.1 Social and Ethical Implications of Genetic Testing
4.2.2 Affordability of Genetic Services
4.3 Market Opportunities
4.3.1 Untapped Emerging Markets in Developing Countries
4.4 Future Trends
4.4.1 Artificial Intelligence-Powered Genetic Testing
4.5 Impact Analysis:
5. Genetic Testing Services Market – North America Market Analysis
5.1 North America Genetic Testing Services Market Revenue (US$ Mn), 2022 – 2030
6. North America Genetic Testing Services Market – Revenue and Forecast to 2030 – by Service Type
6.1 Overview
6.2 North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
6.3 Predictive Testing
6.3.1 Overview
6.3.2 Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Carrier Testing
6.4.1 Overview
6.4.2 Carrier Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Prenatal Testing
6.5.1 Overview
6.5.2 Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Newborn Screening
6.6.1 Overview
6.6.2 Newborn Screening: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Genetic Testing Services Market – Revenue and Forecast to 2030 – by Disease
7.1 Overview
7.2 North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Metabolic Diseases
7.5.1 Overview
7.5.2 Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Other Diseases
7.6.1 Overview
7.6.2 Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Genetic Testing Services Market – Revenue and Forecast to 2030 – by Service Provider
8.1 Overview
8.2 North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
8.3 Hospital-Based Laboratories
8.3.1 Overview
8.3.2 Hospital-Based Laboratories: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Genetic Testing Services Market – Country Analysis
9.1 North America
9.1.1 North America Genetic Testing Services Market, by Country
9.1.1.1 US
9.1.1.1.1 Overview
9.1.1.1.2 US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.1.3 US: North America Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
9.1.1.1.4 US: North America Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
9.1.1.1.5 US: North America Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
9.1.1.2 Canada
9.1.1.2.1 Overview
9.1.1.2.2 Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 Canada: North America Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
9.1.1.2.4 Canada: North America Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
9.1.1.2.5 Canada: North America Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
9.1.1.3 Mexico
9.1.1.3.1 Overview
9.1.1.3.2 Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Mexico: North America Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
9.1.1.3.4 Mexico: North America Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
9.1.1.3.5 Mexico: North America Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10. Genetic Testing Services Market–Industry Landscape
10.1 Overview
10.2 Growth Strategies in Genetic Testing Services Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eurofins Scientific SE
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Exact Sciences Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Laboratory Corp of America Holdings
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 23andMe Holding Co
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Ambry Genetics Corp
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Quest Diagnostics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Illumina Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 F. Hoffmann-La Roche Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 NeoGenomics Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Centogene AG
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

LIST OF TABLES

Table 1.             North America Genetic Testing Services Market Segmentation
Table 2.             US: North America Genetic Testing Services Market, by Service Type – Revenue and Forecast to 2030 (US$ Million)
Table 3.             US: North America Genetic Testing Services Market, by Disease – Revenue and Forecast to 2030 (US$ Million)
Table 4.             US: North America Genetic Testing Services Market, by Service Provider – Revenue and Forecast to 2030 (US$ Million)
Table 5.             Canada: North America Genetic Testing Services Market, by Service Type – Revenue and Forecast to 2030 (US$ Million)
Table 6.             Canada North America Genetic Testing Services Market, by Disease – Revenue and Forecast to 2030 (US$ Million)
Table 7.             Canada: North America Genetic Testing Services Market, by Service Provider – Revenue and Forecast to 2030 (US$ Million)
Table 8.             Mexico: North America Genetic Testing Services Market, by Service Type – Revenue and Forecast to 2030 (US$ Million)
Table 9.             Mexico: North America Genetic Testing Services Market, by Disease – Revenue and Forecast to 2030 (US$ Million)
Table 10.          Mexico: North America Genetic Testing Services Market, by Service Provider – Revenue and Forecast to 2030 (US$ Million)
Table 11.          Recent Organic Growth Strategies in Genetic Testing Services Market
Table 12.          Recent Inorganic Growth Strategies in the Genetic Testing Services Market
Table 13.          Glossary of Terms, Genetic Testing Services Market

LIST OF FIGURES

Figure 1.           North America Genetic Testing Services Market Segmentation, By Country
Figure 2.           North America Genetic Testing Services Market – Key Industry Dynamics
Figure 3.           Impact Analysis of Drivers and Restraints
Figure 4.           North America Genetic Testing Services Market Revenue (US$ Mn), 2022 – 2030
Figure 5.           North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
Figure 6.           Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7.           Carrier Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8.           Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9.           Newborn Screening: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10.        Others: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11.        North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
Figure 12.        Cancer: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13.        Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14.        Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15.        Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16.        North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
Figure 17.        Hospital-Based Laboratories: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18.        Diagnostic Laboratories: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19.        Others: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.        North America Genetic Testing Services Market, by Key Country – Revenue (2022) (US$ Million)
Figure 21.        North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
Figure 22.        US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23.        Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24.        Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25.        Growth Strategies in Genetic Testing Services Market

The List of Companies – North America Genetic Testing Services Market

o 23andMe Holding Co                                         
o Ambry Genetics Corp                                 
o Eurofins Scientific SE       
o Exact Sciences Corp       
o F. Hoffmann-La Roche Ltd                  
o Illumina Inc                                              
o Laboratory Corp of America Holdings          
o NeoGenomics Inc                               
o Quest Diagnostics Inc   
o Centogene AG                     

Reviews

There are no reviews yet.

Be the first to review “North America Genetic Testing Services Market Forecast to 2030”